Weiwei Zhou

2.3k total citations
67 papers, 864 citations indexed

About

Weiwei Zhou is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Weiwei Zhou has authored 67 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Weiwei Zhou's work include Adrenal and Paraganglionic Tumors (19 papers), Hormonal Regulation and Hypertension (17 papers) and Pituitary Gland Disorders and Treatments (11 papers). Weiwei Zhou is often cited by papers focused on Adrenal and Paraganglionic Tumors (19 papers), Hormonal Regulation and Hypertension (17 papers) and Pituitary Gland Disorders and Treatments (11 papers). Weiwei Zhou collaborates with scholars based in China, United States and Poland. Weiwei Zhou's co-authors include Weiqing Wang, Tingwei Su, Lei Jiang, Yiran Jiang, Lihua Bi, Weiping Teng, Zhongyan Shan, Jinyuan Mao, Yang Liu and Shaowei Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Weiwei Zhou

57 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Zhou China 14 504 219 183 118 111 67 864
Levent Kebapçılar Türkiye 22 405 0.8× 324 1.5× 156 0.9× 61 0.5× 111 1.0× 94 1.2k
Serkan Yener Türkiye 22 749 1.5× 532 2.4× 126 0.7× 53 0.4× 183 1.6× 66 1.1k
Pekka Leinonen Finland 15 559 1.1× 100 0.5× 305 1.7× 149 1.3× 85 0.8× 27 1.1k
Matteo Salvi Italy 17 413 0.8× 164 0.7× 181 1.0× 69 0.6× 24 0.2× 44 1.2k
Michèle d’Herbomez France 22 642 1.3× 245 1.1× 174 1.0× 72 0.6× 37 0.3× 39 1.0k
Nuria García de la Torre Spain 18 284 0.6× 393 1.8× 176 1.0× 159 1.3× 403 3.6× 34 1.1k
Baihui Xu China 19 366 0.7× 174 0.8× 159 0.9× 50 0.4× 52 0.5× 31 985
Grzegorz Piecha Poland 19 167 0.3× 139 0.6× 230 1.3× 154 1.3× 84 0.8× 45 948
Koji Mukasa Japan 19 814 1.6× 148 0.7× 144 0.8× 89 0.8× 37 0.3× 31 1.2k
P. S. N. Menon India 20 587 1.2× 208 0.9× 125 0.7× 108 0.9× 73 0.7× 47 1.1k

Countries citing papers authored by Weiwei Zhou

Since Specialization
Citations

This map shows the geographic impact of Weiwei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Zhou more than expected).

Fields of papers citing papers by Weiwei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Zhou. The network helps show where Weiwei Zhou may publish in the future.

Co-authorship network of co-authors of Weiwei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Zhou. A scholar is included among the top collaborators of Weiwei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Zhou. Weiwei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Weiwei, Wei Hui, Arshad Mehmood, et al.. (2024). Countermeasures and management schemes for improving the quality of continuing medical education in hospitals. Perioperative Care and Operating Room Management. 37. 100440–100440.
2.
Jiang, Yiran, et al.. (2024). The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism. Frontiers in Endocrinology. 15. 1369582–1369582. 2 indexed citations
3.
Su, Tingwei, Yifan Yang, Lei Jiang, et al.. (2023). SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis. Frontiers in Endocrinology. 14. 1121397–1121397. 6 indexed citations
4.
Zhou, Lihua, Yiran Jiang, Cui Zhang, et al.. (2023). Effects of a low-sodium diet in patients with idiopathic hyperaldosteronism: a randomized controlled trial. Frontiers in Endocrinology. 14. 1124479–1124479. 6 indexed citations
5.
Zhu, Hongyuan, Tingwei Su, Lei Jiang, et al.. (2023). Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors. Frontiers in Endocrinology. 14. 1199875–1199875. 2 indexed citations
6.
Pan, Lulu, Weiwei Zhou, Minjie Li, et al.. (2022). Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial. Human Vaccines & Immunotherapeutics. 18(6). 2116881–2116881.
7.
Zhou, Weiwei, Weizhe Liu, Chuang Zhang, et al.. (2022). Gentianella acuta improves TAC-induced cardiac remodelling by regulating the Notch and PI3K/Akt/FOXO1/3 pathways. Biomedicine & Pharmacotherapy. 154. 113564–113564. 25 indexed citations
9.
Jiang, Yiran, et al.. (2021). Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism. Frontiers in Molecular Biosciences. 8. 751770–751770. 6 indexed citations
10.
Li, Chunrong, Xin Li, Xian Wang, et al.. (2020). Periostin Mediates Oestrogen‐Induced Osteogenic Differentiation of Bone Marrow Stromal Cells in Ovariectomised Rats. BioMed Research International. 2020(1). 9405909–9405909. 8 indexed citations
11.
Zhang, Jie, Liyun Shen, Jing Xie, et al.. (2020). Mild TPO deficiency characterized by progressive goiter and normal serum TSH level. Endocrine. 68(3). 599–606. 11 indexed citations
12.
Ye, Lei, Tingwei Su, Jing Xie, et al.. (2017). Establishment and evaluation of a novel biomarker‐based nomogram for malignant phaeochromocytomas and paragangliomas. Clinical Endocrinology. 87(2). 127–135. 8 indexed citations
13.
Zhou, Weiwei, et al.. (2016). Short-term study of orally administered Difrarel to control myopia in children. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Zhou, Weiwei, et al.. (2016). The clinical application of adjusted inferior petrosal sinus sampling in Cushing's disease. Zhonghua neifenmi daixie zazhi. 32(3). 196–200. 2 indexed citations
15.
Wang, Weiqing, Lei Ye, Tingwei Su, et al.. (2016). ERBB‐2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas. Clinical Endocrinology. 84(6). 822–829. 7 indexed citations
16.
Wang, Weiqing, Shuwei Wang, Yiran Jiang, et al.. (2015). Relationship between pituitary stalk ( PS ) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited. Clinical Endocrinology. 83(3). 369–376. 22 indexed citations
17.
Zheng, Xulei, Weiqing Wang, Tingwei Su, et al.. (2009). Mutation of SDHB gene in sporadic patients with pheochromocytom. Zhonghua neifenmi daixie zazhi. 25(4). 423–425. 1 indexed citations
18.
19.
Li, Hui, et al.. (2007). Fetal echocardiographic screening in twins for congenital heart diseases. Chinese Medical Journal. 120(16). 1391–1394. 6 indexed citations
20.
Tao, Bei, Jianmin Liu, M Kellis, et al.. (2006). [The relationship between quantitative ultrasound and osteoporosis self-assessment tool for Asians (OSTA) score and non-vertebral fracture in postmenopausal Chinese women].. PubMed. 45(12). 988–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026